DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Breet NJ, van Werkum JW, Bouman HJ. , et al.
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.

Heart 2011;
97 (12) 983-990

Breet NJ, van Werkum JW, Bouman HJ. , et al.
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.

Heart 2011;
97 (12) 983-990

Download Bibliographical Data

Search in:
Access: